GC-MS helps with cancer weight-loss study
Patients receiving EPA supplements did not lose weight

GC, MDGC

GC-MS helps with cancer weight-loss study

13 Apr, 2010

Published over 16 years ago. See the latest and most current information on GC, MDGC.

Gas chromatography-mass spectrometry (GC-MS) has been used by researchers to examine whether omega 3 fats can stop weight reduction in post-surgery cancer sufferers.

Scientists at Trinity College Dublin and New York University explored whether a diet rich in one form of the fat - eicosapentaenoic acid (EPA) - helps prevent the problem.

Esophageal cancer patients were tested in a double-blind randomised test, with both treatment and control groups.

According to the Irish Medical Times, GC-MS techniques - which separates and enables the identification of molecules - were implemented to study immune cells in the lab and revealed a drop in natural killer cells post-operation in the EPA-fed volunteers.

The investigation found patients receiving the nutritional aid experienced no muscle loss at all, while the individuals in the standard test dropped an average of three pounds each.

"Future studies on the health benefits of EPA supplements in cancer patients should be conducted," said lead of the study Professor John Reynolds.

Explore Our Other Sites

Labmate Online
Seventeen cancers found in prospective study of novel multicancer blood test
Explore more Arrow
Envirotech Online
Connected safety technology company announces CEO appointment and leadership transition
Explore more Arrow
Pollution Solutions Online
Smarter wastewater management helps futureproof distillery operations and protect local watercourses
Explore more Arrow
Petro Online
Sustainable fuel lubricity testing in focus at Gulf Coast Conference 2026
Explore more Arrow